Laser & RF Device Selection for Darker Skin Tones (Fitzpatrick IV–VI)

Patients with higher Fitzpatrick skin types can be treated safely and effectively with many laser and energy-based technologies—but the therapeutic window is often narrower.

The underlying physics does not change. What changes is the amount of epidermal melanin competing for laser energy before that energy reaches the intended target. That makes wavelength, pulse duration, fluence, cooling, and treatment endpoint particularly important when treating Fitzpatrick IV–VI skin.

The goal is not simply to use “lower settings.” It is to select the right energy and delivery strategy for the target while minimizing unnecessary epidermal heating and inflammation.

Why Epidermal Melanin Changes the Treatment Window

Laser treatments rely on selective absorption of light by a target chromophore such as melanin, hemoglobin, or tattoo pigment.

In darker skin, increased epidermal melanin can also absorb part of that laser energy. If too much energy is deposited in the epidermis, the risk of overheating, burns, post-inflammatory hyperpigmentation, and hypopigmentation increases.

This is why a setting that is appropriate for one patient may not be appropriate for another—even when the diagnosis is the same.

Successful treatment requires balancing several variables:

• Wavelength: determines absorption and penetration.
• Pulse duration: influences how quickly energy is delivered to the target.
• Fluence: determines the amount of energy delivered.
• Spot size: influences penetration and energy distribution.
• Cooling: helps protect the epidermis during photothermal treatments.
• Clinical endpoint: confirms that enough energy has been delivered without excessive tissue response.

No single parameter determines safety on its own.

Wavelength: Managing Melanin Competition

Melanin absorbs broadly across visible and near-infrared wavelengths, but its absorption generally decreases as wavelength increases. This is why longer wavelengths often provide a wider treatment window in patients with more epidermal melanin.

Among wavelengths commonly used for pigment, vascular, and hair treatments:

• 532 nm: Strongly absorbed by melanin and oxyhemoglobin. It is useful for selected superficial pigment and vascular targets, but epidermal melanin competition increases substantially in darker skin.
• 755 nm Alexandrite: Has strong melanin absorption and is highly effective for hair reduction and selected pigment targets, but requires greater caution as epidermal pigment increases.
• 1064 nm Nd:YAG: Has lower epidermal melanin absorption and greater penetration than 532 or 755 nm, providing an important therapeutic advantage in higher Fitzpatrick skin types.
• Radiofrequency: Does not rely on light absorption by melanin at all, so chromophore competition is not part of its mechanism.

For laser hair reduction in Fitzpatrick IV–VI skin, long-pulsed 1064 nm Nd:YAG is particularly well established because its deeper penetration and lower epidermal melanin absorption provide a greater margin between the epidermis and the follicular target.

Long-Pulsed 1064 nm: Hair and Vascular Applications

Wavelength alone does not determine the tissue response. Pulse duration must also match the target.

For hair reduction and vascular treatments, 1064 nm is typically delivered in millisecond pulses. Extending the pulse allows energy to be deposited over a longer period rather than instantaneously, creating controlled photothermal heating of the target.

In hair reduction, the goal is to thermally damage follicular structures while limiting excessive heating of epidermal melanin. Longer pulse durations, appropriate fluence, larger spot sizes, and effective epidermal cooling can all contribute to a wider therapeutic window in darker skin.

SANDRO DUAL combines long-pulsed 755 nm Alexandrite and 1064 nm Nd:YAG in one system, allowing clinicians to select the wavelength based on the patient's skin type, hair characteristics, and treatment goal rather than approaching every patient with the same wavelength. WONTECH lists the platform for hair reduction and vascular applications across skin types.

For vascular treatment, V-LASER combines long-pulsed 532 nm KTP and 1064 nm Nd:YAG. The 532 nm wavelength provides strong absorption by superficial vascular targets, while 1064 nm provides deeper penetration with less competition from epidermal melanin—an especially important distinction as skin type increases.

Short Pulses Require a Different Strategy

The relationship between pulse duration and darker skin is different when treating pigment and tattoo ink.

Q-switched and picosecond lasers intentionally use extremely short pulses because melanosomes and tattoo particles are very small targets. These short pulses produce high peak powers and strong photomechanical or photoacoustic effects.

Here, the goal is not to simply lengthen the pulse to protect the epidermis. Instead, clinicians manage risk through the combination of wavelength selection, fluence, spot size, pulse characteristics, treatment density, repetition, and clinical endpoint.

A 1064 nm Q-switched or picosecond wavelength can be particularly valuable because it retains the lower epidermal melanin absorption of 1064 nm while providing the short pulse durations needed to target pigment or ink.

PASTELLE PRO combines Q-switched 1064 nm and 532 nm delivery for applications including toning, pigmented lesions, and tattoo removal.

PICO MAJESTY delivers 250-picosecond pulses at 1064 nm and 532 nm for pigmentation, tattoo removal, and skin revitalization. The very short pulse duration increases the photoacoustic contribution while reducing the time available for heat to diffuse into surrounding structures.

Pulse Duration, Fluence, Cooling—and Context

It is tempting to reduce treatment of darker skin to a few rules: use 1064 nm, lower the fluence, lengthen the pulse, and add cooling.

The reality is more nuanced.

Pulse Duration

For photothermal treatments such as hair reduction and vascular lesions, longer pulse durations can help distribute energy over time and improve epidermal safety.

For pigment and tattoo treatments, Q-switched and picosecond pulses are intentionally extremely short. Safety comes from matching the wavelength and energy delivery to the target—not simply increasing pulse duration.

Fluence

Conservative energy selection is important, but “low fluence” is not universally safer or more effective. Fluence must be interpreted alongside wavelength, spot size, pulse duration, treatment density, and endpoint.

Cooling

Epidermal cooling is particularly important during long-pulsed photothermal treatments. Contact cooling, cryogen, and other cooling systems can help limit unwanted epidermal heating while therapeutic temperatures are created deeper in the tissue.

Spot Size

Spot size affects more than treatment speed. Larger spot sizes can increase effective penetration because less energy is lost to scattering, making spot-size selection part of the overall treatment strategy.

Where Radiofrequency Fits

Radiofrequency works differently from laser.

Rather than delivering a wavelength that must be absorbed by a chromophore, RF creates heat through the tissue's resistance to electrical current. Melanin is not the target and does not compete for RF energy.

This makes RF particularly useful when the goal is collagen remodeling, improved firmness, or facial contouring in patients across a broad range of skin tones.

However, melanin-independence should not be interpreted as risk-independence. Excessive heat or inflammation can still provoke pigmentary change in susceptible patients, so controlled energy delivery, patient selection, and appropriate endpoints remain important.

OLIGIO and OLIGIO-X are 448 kHz monopolar RF platforms designed for controlled dermal heating and collagen remodeling. OLIGIO incorporates real-time impedance monitoring, while OLIGIO-X adds integrated contact cooling and real-time temperature feedback to help clinicians monitor energy delivery during treatment.

Building a Device Menu for a Diverse Patient Population

A practice does not need one device that attempts to treat every patient and every indication.

A more useful goal is clinical coverage: having enough wavelength and energy options to choose the appropriate modality for the patient in front of you.

For a practice treating a broad range of skin types, useful questions include:

• Do we have 1064 nm long-pulsed capability for hair and vascular treatment?
• Do we have 1064 nm Q-switched or picosecond capability for pigment and tattoo applications?
• Can we choose between shorter and longer wavelengths rather than forcing one wavelength to treat every target?
• Do we have a non-light-based option such as RF when chromophore competition makes laser less desirable for the treatment goal?
• Does our clinical team understand how wavelength, pulse duration, fluence, spot size, and cooling interact in higher Fitzpatrick skin types?

The versatility of the treatment menu matters more than the number of devices on the floor.

Fitzpatrick Type Is a Starting Point, Not the Entire Assessment

Fitzpatrick skin typing is useful, but it was originally developed around a patient's tendency to burn or tan after ultraviolet exposure. It does not directly measure epidermal melanin concentration, and patients classified within the same Fitzpatrick type can still have very different skin tones and laser responses.

A thorough laser consultation should therefore consider more than the Fitzpatrick number.

Relevant factors include:

• Current skin tone and degree of epidermal pigmentation
• Recent tanning or UV exposure
• Ethnic background and pigmentary response
• Previous laser or light-based treatments
• History of post-inflammatory hyperpigmentation or hypopigmentation
• Medications and photosensitizing agents
• The specific diagnosis and depth of the target
• Previous treatment response

When appropriate, conservative test spots and adequate observation before full treatment can provide additional information about an individual's response.

The Goal Is a Wider Therapeutic Window

Treating darker skin successfully is not simply about turning the energy down.

It is about creating the largest possible separation between effective treatment of the intended target and unwanted injury to the epidermis.

That may mean choosing 1064 nm instead of a shorter wavelength, adjusting pulse duration, modifying fluence or spot size, increasing epidermal protection, selecting an ultra-short-pulse technology for pigment, or choosing RF when the treatment goal does not require a chromophore at all.

The best platform is therefore not necessarily the one with the most power. It is the one that gives the clinician enough control and enough options to match the energy to the patient, the target, and the treatment goal.

WONTECH devices are intended for use by licensed medical professionals. Individual treatment suitability and parameters vary by patient, diagnosis, and skin type. Product availability, indications, and regulatory clearance may vary by market.